ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Dec 02, 2021 15:00 JST
Source:
Olympus
Olympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World)
TOKYO, Dec 02, 2021 - (JCN Newswire) - Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) has been selected for inclusion in the 2021 Dow Jones Sustainability World Index (DJSI World) and the 2021 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), among the world's most recognized corporate sustainability indices. Olympus is admitted to the DJSI World for the first time this year and in the DJSI Asia Pacific for the third consecutive year.
The Dow Jones Sustainability Indices (DJSI) are corporate sustainability evaluation indices for environmental, social and governance (ESG) investment. Jointly developed by S&P Dow Jones Indices and RobecoSAM, the DJSI track the financial performance of leading companies in terms of ESG criteria. Companies with excellent corporate sustainability practices are assured and selected annually.
In 2021, 322 companies were selected as DJSI World members from approximately 3500 companies in 61 industry sectors that were evaluated worldwide, and 153 companies were selected as DJSI Asia Pacific members from approximately 600 companies assessed in the region. Olympus is one of only 10 out of 84 companies to have been selected as DJSI World in the Health Care Equipment & Supplies sector. Our scores on Corporate Governance, Innovation Management, Operational Eco-Efficiency, Occupational Health and Safety initiatives have improved this year and those efforts were highly rated.
In addition to DJSI World and DJSI Asia Pacific, Olympus was also named in the FTSE4Good Index Series and FTSE Blossom Japan Index.
Based on Our Purpose of "Making people's lives healthier, safer and more fulfilling," Olympus believes that the sustainability of a company will be recognized primarily by meeting the demands and expectations of society and fulfilling our responsibilities through dialogue with all stakeholders. Since announcing our material issues (materiality)*1 at the beginning of our Corporate Strategy in 2019, we have further strengthened our efforts to address ESG challenges. We will continue to contribute to a sustainable society by actively engaging in activities that incorporate ESG perspectives to fulfill our corporate social responsibilities on a global scale.
For more information on our ESG initiatives, please refer to the Integrated Report 2021*2 and the Sustainability Report 2021*3.
*1: The following five materiality items were identified; "Healthcare access and outcomes", "Compliance, product quality and safety", "Responsible supply chain", "Diversity and inclusion", and "Carbon neutral society and circular economy" (this item was added in May, 2021).
*2:
https://www.olympus-global.com/ir/data/integratedreport/pdf/integrated_report_2021e_A4.pdf
*3:
https://www.olympus-global.com/csr/download/pdf/Olympus_Sustainability_Report_2021e.pdf
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease; furthering scientific research; and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 30,000 employees worldwide in nearly 40 countries and regions. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp.
Olympus Contact (Tokyo)
Yuka Horimoto
+81-90-2490-1071
yuka.horimoto@olympus.com
Source: Olympus
Sectors: Environment, ESG, Daily News, BioTech, Healthcare & Pharm, Funds & Equities, Local Biz, MedTech, Clinical Trials
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status
Nov 01, 2024 13:56 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Nov 01, 2024 12:43 JST
Fujitsu's groundbreaking computing technology for accelerating scientific computing wins Japan Patent Office Commissioner's Award
Nov 01, 2024 12:24 JST
Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives
Nov 01, 2024 10:45 JST
Mazda Launches Redesigned Corporate Website
Oct 31, 2024 17:06 JST
NTT and Toyota Motor Corporation agree to joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents
Oct 31, 2024 16:34 JST
All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024
Oct 31, 2024 16:08 JST
Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference
Oct 31, 2024 13:56 JST
Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)
Oct 31, 2024 11:33 JST
Mazda Production and Sales Results for September 2024 and for April through September 2024
Oct 30, 2024 17:09 JST
Suzuki and Toyota to Deepen Collaboration in the Field of Electrified Vehicles
Oct 30, 2024 16:14 JST
Fujitsu and Morinaga Milk Industry jointly develop a simulation system for raw material price fluctuations, speeding up decision-making
Oct 30, 2024 13:43 JST
DOCOMO to Participate in Virtual Expo at Expo 2025 Osaka, Kansai, Japan
Oct 30, 2024 12:47 JST
ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea
Oct 30, 2024 11:00 JST
Fujitsu and Linius partner to unlock the power of video worldwide
Oct 29, 2024 19:53 JST
DENSO and U.S. Startup Quadric Sign Development License Agreement for AI Semiconductor (NPU)
Oct 29, 2024 13:03 JST
Toyota Motor Corporation and Hyundai Motor Company Co-host Motorsport Event to Share the Excitement of Racing
Oct 28, 2024 20:53 JST
NEC launches new end to end private 5G solution with Cisco
Oct 28, 2024 17:05 JST
Mitsubishi Power Receives Order for Facility Retrofit at the Darajat Geothermal Power Plant in Indonesia
Oct 28, 2024 15:35 JST
GS Holdings to Acquire Integrated Beverage Solutions Group, Octopus Distribution Networks, for S$11.8 Million; Expected to Yield Significant Opportunities and Additional Financial Benefits
Oct 28, 2024 09:00 JST
More Latest Release >>
Related Release
Olympus Launches VISERA S, a New Imaging Platform
9/30/2024 3:00:00 PM JST
Olympus Launches New 4K Camera Head for Urological Endoscopy
9/20/2024 3:00:00 PM JST
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
6/12/2024 11:00:00 AM JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
3/27/2024 3:00:00 PM JST
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
1/24/2024 3:00:00 PM JST
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
12/11/2023 11:00:00 AM JST
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
12/7/2023 11:00:00 AM JST
Olympus's Net-Zero Targets Approved by SBTi
11/30/2023 11:00:00 AM JST
Olympus Names Dr. John de Csepel as Chief Medical Officer
10/6/2023 9:00:00 PM JST
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
7/20/2023 11:00:00 AM JST
More Press release >>